Lam Research Valuation
Is LRCX * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of LRCX * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: LRCX * (MX$14912.6) is trading above our estimate of fair value (MX$8183.84)
Significantly Below Fair Value: LRCX * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for LRCX *?
Other financial metrics that can be useful for relative valuation.
What is LRCX *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$120.98b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 8.4x |
Enterprise Value/EBITDA | 27.2x |
PEG Ratio | 2.1x |
Price to Earnings Ratio vs Peers
How does LRCX *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 38x | ||
8035 Tokyo Electron | 44.3x | 20.2% | JP¥15.8t |
KLAC KLA | 36.4x | 17.6% | US$95.1b |
AMAT Applied Materials | 23.6x | 6.3% | US$169.0b |
ASML ASML Holding | 47.5x | 20.0% | €337.6b |
LRCX * Lam Research | 33.5x | 16.3% | Mex$121.0b |
Price-To-Earnings vs Peers: LRCX * is good value based on its Price-To-Earnings Ratio (33.5x) compared to the peer average (38x).
Price to Earnings Ratio vs Industry
How does LRCX *'s PE Ratio compare vs other companies in the Global Semiconductor Industry?
Price-To-Earnings vs Industry: LRCX * is expensive based on its Price-To-Earnings Ratio (33.5x) compared to the Global Semiconductor industry average (32.2x).
Price to Earnings Ratio vs Fair Ratio
What is LRCX *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 33.5x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate LRCX *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | Mex$16,677.53 0% | 10.5% | Mex$20,575.92 | Mex$11,659.69 | n/a | 29 |
Apr ’25 | n/a | Mex$15,333.05 0% | 10.1% | Mex$18,982.64 | Mex$11,087.21 | n/a | 29 |
Mar ’25 | Mex$15,757.09 | Mex$15,099.41 -4.2% | 9.4% | Mex$16,678.23 | Mex$11,232.28 | n/a | 29 |
Feb ’25 | Mex$14,190.00 | Mex$15,012.47 +5.8% | 10.7% | Mex$16,878.05 | Mex$11,366.85 | n/a | 29 |
Jan ’25 | Mex$13,474.00 | Mex$12,428.70 -7.8% | 11.4% | Mex$15,179.96 | Mex$9,433.88 | n/a | 29 |
Dec ’24 | Mex$12,275.10 | Mex$12,203.14 -0.6% | 9.4% | Mex$14,324.97 | Mex$9,549.98 | n/a | 28 |
Nov ’24 | n/a | Mex$12,632.87 0% | 9.0% | Mex$14,988.93 | Mex$9,992.62 | n/a | 27 |
Oct ’24 | Mex$11,071.06 | Mex$12,228.44 +10.5% | 9.9% | Mex$14,483.04 | Mex$9,567.58 | n/a | 25 |
Sep ’24 | Mex$11,166.07 | Mex$11,581.76 +3.7% | 9.4% | Mex$13,417.60 | Mex$9,140.74 | n/a | 24 |
Aug ’24 | Mex$11,800.00 | Mex$11,625.87 -1.5% | 9.4% | Mex$13,489.04 | Mex$9,189.41 | n/a | 24 |
Jul ’24 | n/a | Mex$9,893.64 0% | 11.1% | Mex$12,380.97 | Mex$8,538.60 | n/a | 23 |
Jun ’24 | n/a | Mex$9,817.87 0% | 10.5% | Mex$12,824.09 | Mex$8,401.99 | n/a | 22 |
May ’24 | n/a | Mex$9,756.42 0% | 6.9% | Mex$11,163.29 | Mex$8,552.52 | n/a | 22 |
Apr ’24 | n/a | Mex$9,806.48 0% | 8.2% | Mex$11,531.07 | Mex$8,369.33 | n/a | 22 |
Mar ’24 | n/a | Mex$9,445.12 0% | 11.7% | Mex$11,391.94 | Mex$5,677.60 | Mex$15,757.09 | 22 |
Feb ’24 | Mex$9,600.00 | Mex$9,579.68 -0.2% | 11.4% | Mex$11,545.02 | Mex$5,753.89 | Mex$14,190.00 | 23 |
Jan ’24 | Mex$7,880.59 | Mex$8,925.24 +13.3% | 19.7% | Mex$12,249.09 | Mex$5,926.98 | Mex$13,474.00 | 23 |
Dec ’23 | n/a | Mex$8,550.95 0% | 19.6% | Mex$11,959.86 | Mex$5,787.03 | Mex$12,275.10 | 23 |
Nov ’23 | n/a | Mex$8,556.35 0% | 18.8% | Mex$12,317.79 | Mex$5,960.22 | n/a | 23 |
Oct ’23 | n/a | Mex$11,294.67 0% | 13.6% | Mex$14,488.56 | Mex$8,149.82 | Mex$11,071.06 | 23 |
Sep ’23 | Mex$8,930.00 | Mex$11,548.69 +29.3% | 14.9% | Mex$16,112.72 | Mex$9,063.41 | Mex$11,166.07 | 24 |
Aug ’23 | Mex$9,180.00 | Mex$11,686.56 +27.3% | 15.2% | Mex$16,307.28 | Mex$9,172.85 | Mex$11,800.00 | 23 |
Jul ’23 | Mex$8,001.98 | Mex$12,702.85 +58.7% | 15.4% | Mex$16,909.96 | Mex$10,266.76 | n/a | 24 |
Jun ’23 | Mex$10,480.00 | Mex$12,769.76 +21.8% | 13.7% | Mex$16,615.03 | Mex$10,285.50 | n/a | 24 |
May ’23 | Mex$9,525.00 | Mex$13,110.62 +37.6% | 13.7% | Mex$16,965.65 | Mex$10,502.54 | n/a | 23 |
Apr ’23 | Mex$10,874.60 | Mex$14,444.08 +32.8% | 10.0% | Mex$17,385.91 | Mex$11,003.74 | n/a | 24 |
Analyst Forecast: Target price is less than 20% higher than the current share price.